-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

508.O1.6 508. Bone Marrow Failure: Acquired: Unraveling the Future of PNH Therapy From Clinical Trials Clinically Relevant Abstract

Symposia: Bone Marrow Failure: Acquired Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Acquired Marrow Failure Syndromes, Biological therapies, adult, Bone Marrow Failure Syndromes, Bispecific Antibody Therapy, Clinical Research, Combination therapy, Paroxysmal Nocturnal Hemoglobinuria, Diseases, Therapies, Infusion, young adult , Monoclonal Antibody Therapy, Study Population, Human
Sunday, December 10, 2023: 4:30 PM-6:00 PM
Room 7 (San Diego Convention Center)
Moderators:
Pedro H. Prata, MD, PhD, Hopital Saint-Louis and Jamile Shammo, MD, Northwestern University
Disclosures:
Prata: SOBI: Consultancy, Honoraria; Alexion: Consultancy, Honoraria.
This session will include phase I data of novel agents for PNH, extended phase II/III clinical trial data on emerging therapies, and long term follow up of approved C3 inhibitors.
4:30 PM

Antonio M Risitano, MD, PhD1,2, Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP3,4,5, Alexander Röth, MD6, Phillip Scheinberg, MD7, Yasutaka Ueda8*, Carlos de Castro9*, Eros Di Bona10*, Morag Griffin, FRCPath, MRCP11*, Saskia MC Langemeijer, MD, PhD12*, Hubert Schrezenmeier, MD13,14, Wilma Barcellini, MD15*, Vitor AQ Mauad, MD16*, Jens Panse, MD17,18, Philippe Schafhausen19*, Suzanne Tavitian, MD20*, Eloise Beggiato21*, Anna Gaya22*, Wei-Han Huang23*, Toshio Kitawaki, MD24*, Abdullah Kutlar, MD25*, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP26, Rosario Notaro27,28*, Vinod Pullarkat, MD29, Jörg Schubert30*, Louis Terriou, M.D31*, Michihiro Uchiyama32*, Flore Sicre De Fontbrune33*, Camilla Frieri1,2*, Ferras Alashkar6*, Shreyans Gandhi3*, Rakesh Kumar34*, Christine Thorburn35*, Samopriyo Maitra34*, Susan Solar-Yohay36*, Tomasz Lawniczek37*, Marion Dahlke, MD, MSc38* and Régis Peffault De Latour33,39*

1AORN Moscati, Avellino, Italy
2University of Naples Federico II, Naples, Italy
3King’s College Hospital NHS, London, United Kingdom
4National Institute for Health and Care Research and Wellcome King’s Research Facility, London, United Kingdom
5King’s College London, London, United Kingdom
6West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany
7Hospital A Beneficência Portuguesa, São Paulo, Brazil
8Osaka University Graduate School of Medicine, Suita, Japan
9Duke University School of Medicine, Durham, NC
10UOC Oncoematologia, AULSS7 Pedemontana, Bassano del Grappa (VI), Vicenza, Italy
11St James’s University Hospital, Leeds, United Kingdom
12Radboud University Medical Center, Nijmegen, Netherlands
13University of Ulm, Ulm, Germany
14German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm, Germany
15Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
16ABC Medical School, Santo André, Brazil
17University Hospital RWTH Aachen, Aachen, Germany
18Center for Integrated Oncology (CIO) Aachen Bonn Cologne Düsseldorf, Aachen, Germany
19Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
20Centre Hospitalo-Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Service d’Hématologie, Toulouse, France
21University of Torino, Turin, Italy
22Hospital Clinic of Barcelona, Barcelona, Spain
23Hualien Tzu Chi Hospital, Hualien, Taiwan
24Kyoto University, Kyoto, Japan
25Department of Medicine, Medical College of Georgia, Augusta, GA
26Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
27Azienda Ospedaliera Universitaria Careggi, Firenze, Italy
28Instituto per lo Studio, la Prevenzione e la Rete Oncologica, Firenze, Italy
29City of Hope National Medical Center, Duarte, CA
30Elblandklinikum Riesa, Riesa, Germany
31CHU Lille, Université de Lille, Lille, France
32Japanese Red Cross Society Suwa Hospital, Suwa, Japan
33French Référence Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Paris, France
34Novartis Healthcare Private Limited, Hyderabad, India
35Novartis Pharmaceuticals UK Limited, London, United Kingdom
36Novartis Pharmaceuticals Corporation, East Hanover, NJ
37Novartis Pharma AG, Basel, Switzerland
38Novartis, Basel, Switzerland
39Assistance Publique Hôpitaux de Paris, Université Paris Cité, Paris, France

4:45 PM

Fengkui Zhang1*, Li Zhang1*, Chen Yang2*, Chunrong Wang3*, Changhe Yue3*, Hui Yan3*, Jay Ma4*, Helen Fu5*, Chaomei He5*, Ping Tsui5*, Jingtao Wu5*, Richard Lee5*, Wenru Song5 and Bing Han2*

1Anemia Therapeutic Center, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
2Peking Union Medical College Hospital, Beijing, China
3Kira Pharmaceuticals (Suzhou) Limited, Suzhou, China
4Kira Pharmaceuticals (US), Bethany, CT
5Kira Pharmaceuticals (US), Boston, MA

5:00 PM

Oksana Karnabeda, MD1,2*, Valentyn Moskalenko, MD, PhD1*, Zoreslava Lysak, MD1*, Narinder Nangia, PhD3*, Charlotte A. Osborne3*, J. Steve Whitaker, MD3*, Eleni Gavriilaki, MD, PhD4 and Jens Panse, MD5,6

1Medical Centre of ARENSIA Exploratory Medicine LLC, Kyiv, Ukraine
2Bogomolets National Medical University, Kyiv, Ukraine
3Omeros Corporation, Seattle, WA
4G. Papanikolaou General Hospital, Thessaloniki, Greece
5Universitätsklinikum RWTH Aachen, Aachen, Germany
6Center of Integrated Oncology (CIO), Aachen, Bonn, Cologne, Düsseldorf (ABCD), Germany

5:15 PM

Carlos M de Castro, MD1, Brian Mulherin, MD2,3*, Christopher J. Patriquin4*, Veena Selvaratnam, MBBS, FRCPath5*, Raymond SM Wong, FRCP6, Richard J. Kelly, BSc, MD7*, Lisa Tan8,9*, Peter Hillmen, MD10*, Dale Zhang11*, Jessica Savage11* and Regis Peffault De Latour12,13*

1Department of Medicine, Duke University, Durham, NC
2Ascension St. Vincent Carmel, Carmel, IN
3Hematology Oncology of Indiana, Indianapolis, IN
4Division of Medical Oncology & Hematology, University Health Network, Toronto, Canada
5Ampang Hospital, Ampang, Malaysia
6The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, Hong Kong
7Department of Haematology, St. James’s University Hospital, Leeds, United Kingdom
8Swedish Orphan Biovitrum AB, Stockholm, Sweden
9Lisa Tan Pharma Consulting Ltd., Cambridge, United Kingdom
10Apellis Pharmaceuticals, Waltham, MA
11Apellis Pharmaceuticals, Inc., Waltham, MA
12French Référence Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Paris, France
13Université Paris Cité, Paris, France

5:30 PM

Alexander Röth, MD1, Rong FU, MD2*, Guangsheng He3*, Hazza A Alzahrani4*, Sheng-Chieh Chou5*, Yosr Hicheri6*, Maciej Kazmierczak, MD7*, Viviane Lacorte Recova8*, Michihiro Uchiyama9*, ANA Maria Vladareanu10*, Leigh Beveridge, MBBS, FRACP11, Simon Buatois12*, Muriel Buri12*, Dayu Shi13*, Nadiesh Balachandran14*, Sasha Srekovic11* and Phillip Scheinberg, MD15

1University Hospital Essen, Essen, Germany
2tianjin medical university general hospital, TIANJIN, CHN
33. Jiangsu Province Hospital, Nanjing, People’s Republic of China, NANJING, CHN
4Department of Hematology, King Faisal Specialist Hospital & Research Centre., Riyadh, Saudi Arabia
5Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan
6Department of Hematology, Department of Hematology, Institut Paoli Calemettes, Marseille, France, Montpellier, FRA
7Maria Skłodowska-Curie National Research Institute of Oncology, Krakow, Krakow, Poland
88. Chronos Clinical Research, Brasília-DF, Brazil, Brasilia, Brazil
9Japanese Red Cross Society Suwa Hospital, Nagano, JPN
10Department of internal medicine, 10. Department of Internal Medicine II and Gastroenterology, Emergency University Hospital, Bucharest, BUCURESTI, ROU
11Genentech, Inc., South San Francisco, CA, USA, San Fransisco, CA
12F. Hoffmann-La Roche Ltd, Basel, Switzerland
13F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland
14F. Hoffmann-La Roche Ltd., Basel, Switzerland
15Hospital A Beneficência Portuguesa de São Paulo, Sao Paulo, SP, Brazil

5:45 PM

Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP1, Morag Griffin, FRCPath, MRCP2*, Caroline I Piatek, MD3, Jamile Shammo, MD4, Jun-Ichi Nishimura, MD, PhD5, Christopher J. Patriquin6*, Hubert Schrezenmeier, MD7, Anna Gaya, MD8*, Yogesh Patel9*, Peng Liu9*, Gleb Filippov, MD9*, Flore Sicre De Fontbrune10*, Antonio M Risitano, MD, PhD11 and Jong-Wook Lee, MD12

1King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King’s Clinical Research Facility, London, United Kingdom
2Department of Haematology, Leeds Teaching Hospitals, Leeds, GBR
3University of Southern California / LAC+USC Medical Center, Los Angeles, CA
4Feinberg School of Medicine, Northwestern University, Chicago, IL
5Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
6Division of Medical Oncology & Hematology, University Health Network, Toronto, Canada
7Institute of Transfusion Medicine, University of Ulm, Ulm, Germany and Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, University Hospital of Ulm and German Red Cross Blood Service Baden-Württemberg-Hessen, Ulm, Germany
8Hospital Clínic de Barcelona, Barcelona, Spain
9Alexion, AstraZeneca Rare Disease, Boston, MA
10Centre de Référence Aplasie Médullaire, Service d'Hématologie Greffe, Assistance Publique des Hôpitaux de Paris, Hôpital Saint-Louis, PARIS, FRA
11Federico II University of Naples and AORN Moscati, Naples, Italy
12Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

*signifies non-member of ASH